Glioblastoma exosomes reprogramming the tumor microenvironment and evading therapeutic challenges
- 19 February 2026
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 400
Abstract
Glioblastoma (GBM) leverages exosomes to drive tumor progression, immunosuppression, and therapy resistance through transfer of oncogenic miRNAs, circRNAs, and proteins. These vesicles reprogram the tumor microenvironment (TME) by activating pathways such as TREM1 in microglia and STAT3-mediated vasculogenic mimicry. Exosomal nucleic acids, including circZNF800 and miR-374b-3p, serve as non-invasive biomarkers for recurrence and treatment monitoring. Advances in engineering, such as Angiopep-2-functionalized exosomes for blood-brain barrier penetration and CRISPR-Cas9-loaded vesicles targeting resistance genes, highlight their therapeutic potential. Challenges in heterogeneity, standardization, and scalable production underscore the need for interdisciplinary innovation to translate exosome-based strategies into clinical practice.Keywords
Funding Information
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU-DDRSP2501)
This publication has 79 references indexed in Scilit:
- Glioblastoma- derived exosomes (GBM-Exo) regulate microglial M2 polarization via the RAC1/AKT/NRF2 pathwayJournal of Neuro-Oncology, 2025
- Hypoxic Secretome and Exosomes Derived From Human Glioblastoma Cells (U87MG) Promote Protumorigenic Phenotype of Microglia in VitroJournal of Cellular Biochemistry, 2025
- Correction to “Doxorubicin‐loaded nanoparticle coated with endothelial cells‐derived exosomes for immunogenic chemotherapy of glioblastoma”Bioengineering & Translational Medicine, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Glioma stem cell‐derived exosomes induce the transformation of astrocytes via the miR‐3065‐5p/DLG2 signaling axisGlia, 2024
- Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma ImmunotherapyAdvanced Science, 2023
- T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastomaJournal of Neuro-Oncology, 2023
- Exosome Processing and Characterization Approaches for Research and Technology DevelopmentAdvanced Science, 2022
- Exosomal miR‐21‐5p derived from cisplatin‐resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1Cell Biology International, 2021
- Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture mediumJournal of Extracellular Vesicles, 2020